Compile Data Set for Download or QSAR
Report error Found 47 Enz. Inhib. hit(s) with all data for entry = 8577
TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259953(US9512121, 37)
Affinity DataIC50: 2.20nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259964(US9512121, 48)
Affinity DataIC50: 2.40nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259956(US9512121, 40)
Affinity DataIC50: 2.5nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM50182493(CHEMBL3818247 | US9512121, 22)
Affinity DataIC50: 2.90nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259930(US9512121, 5)
Affinity DataIC50: 3.10nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259957(US9512121, 41)
Affinity DataIC50: 3.20nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259931(US9512121, 6)
Affinity DataIC50: 3.30nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259944(US9512121, 28)
Affinity DataIC50: 3.60nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259928(US9512121, 3)
Affinity DataIC50: 3.90nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259960(US9512121, 44)
Affinity DataIC50: 4.40nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259952(US9512121, 36)
Affinity DataIC50: 4.60nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259927(US9512121, 2)
Affinity DataIC50: 4.90nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259955(US9512121, 39)
Affinity DataIC50: 5nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259942(US9512121, 26)
Affinity DataIC50: 5.5nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259963(US9512121, 47)
Affinity DataIC50: 5.70nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259945(US9512121, 29)
Affinity DataIC50: 7.10nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM50182518(CHEMBL3819436 | US9512121, 19)
Affinity DataIC50: 7.90nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259938(US9512121, 17)
Affinity DataIC50: 8.5nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259933(US9512121, 10)
Affinity DataIC50: 8.60nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM50182519(CHEMBL3818738 | US9512121, 18)
Affinity DataIC50: 9.30nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259948(US9512121, 32)
Affinity DataIC50: 10nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259958(US9512121, 42)
Affinity DataIC50: 10.7nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259929(US9512121, 4)
Affinity DataIC50: 11.3nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM50182517(CHEMBL3818928 | US9512121, 21)
Affinity DataIC50: 11.4nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM50182492(CHEMBL3818387 | US9512121, 16)
Affinity DataIC50: 12nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259936(US9512121, 14)
Affinity DataIC50: 12.1nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259947(US9512121, 31)
Affinity DataIC50: 12.1nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259939(US9512121, 23)
Affinity DataIC50: 13.9nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259940(US9512121, 24)
Affinity DataIC50: 15.3nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259932(US9512121, 9)
Affinity DataIC50: 17.8nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM50182495(CHEMBL3818361 | US9512121, 20)
Affinity DataIC50: 20.1nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259935(US9512121, 12)
Affinity DataIC50: 28.3nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259949(US9512121, 33)
Affinity DataIC50: 35.9nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM50182554(CHEMBL3818731 | US9512121, 8)
Affinity DataIC50: 37nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259937(US9512121, 15)
Affinity DataIC50: 42.5nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259962(US9512121, 46)
Affinity DataIC50: 43nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259941(US9512121, 25)
Affinity DataIC50: 56.6nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259946(US9512121, 30)
Affinity DataIC50: 122nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM50182528(CHEMBL3818743 | US9512121, 7)
Affinity DataIC50: 123nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259951(US9512121, 35)
Affinity DataIC50: 175nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259961(US9512121, 45)
Affinity DataIC50: 211nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259934(US9512121, 11)
Affinity DataIC50: 309nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259950(US9512121, 34)
Affinity DataIC50: 440nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259959(US9512121, 43)
Affinity DataIC50: 462nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259954(US9512121, 38)
Affinity DataIC50: 485nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM259943(US9512121, 27)
Affinity DataIC50: 608nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM50182494(CHEMBL3817891 | US9512121, 13)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Experimental Purpose: The purpose is to study the effect of the compounds on c-MET tyrosine kinase activity at the molecular level. IC50 values were ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent